Masimo's MASI short percent of float has risen 3.19% since its last report. The company recently reported that it has 3.13 million shares sold short , which is 8.42% of all regular shares that are ...

Masimo Corporation refocuses on healthcare, projecting 8-11% growth by 2025. Click for why despite progress and solid fundamentals, MASI shares appear overvalued.

Apple wins in patent infringement lawsuit with wearable maker Masimo, but fails to get the injunction on sales that it sought. Skip to main content Thursday 26 June 2025 . BlueSky linkedin youtube ...

Our Top 5 Analyst Questions Masimo’s Q1 Earnings Call. Frederick Wise (Stifel) asked about the impact of the large tender contract on future quarters.

Masimo reported revenues of $372 million, up 9.5% year on year. This print exceeded analysts’ expectations by 1.1%. Despite the top-line beat, it was still a mixed quarter for the company with ...

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia By Business Wire. Updated June 10, 2025 8:19 AM.

Find the latest institutional holdings data for Masimo Corporation Common Stock (MASI) including shareholders, ownership summaries, and holding activities at Nasdaq.com.

Masimo, Kiani legal teams include firms involved in prior case Judge cited high standards for motions to disqualify counsel Hueston Hennigan LLP may continue representing the ousted founder of Masimo ...

In the study, children aged 1 to 6 years scheduled for elective surgery involving at least 30 minutes of general anesthesia at the largest children's hospital in Japan were randomly assigned to an ...